Wolfe Research analyst Scott Group downgrades Alaska Air Gr (NYSE:ALK) from Outperform to Peer Perform.
Stifel Maintains Buy on Rocket Pharmaceuticals, Lowers Price Target to $56
Stifel analyst Dae Gon Ha maintains Rocket Pharmaceuticals (NASDAQ:RCKT) with a Buy and lowers the price target from $67 to $56.